Report comment

There are risks that will be overlooked. As an example, patients who are allergic to (as in, death will result) the cheapest insulins. In the US, securing an override or exception takes such a long time and the process is so protracted that individuals end up on a version of the 'dark web' trading insulin vials. This is not a stretch - it's fact. Extrapolate that out to the full contents of a national formulary content and the problem is self-evident.